Effects of perfluorohexane vapor in the treatment of experimental lung injury

Pulmonary Pharmacology and Therapeutics

Volumn 23, Issue 5, 2010, Pages 450-455

  Bleyl, Jörg U ^a   Heller, Axel R ^a   Heintz, Manuel ^a   Schlemmer, Matthias ^a   Koch, Roland ^b   Gama de Abreu, Marcelo ^a   Hübler, Matthias ^a   Spieth, Peter M ^a,c   Koch, Thea ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Acute lung injury; Fluorocarbons; Isolated rabbit lung; Perfluorohexane vapor

Indexed keywords

CALCIUM IONOPHORE; LEUKOTRIENE B4; PERFLEXANE; PROSTACYCLIN; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LUNG ARTERY PRESSURE; LUNG INJURY; LUNG PERFUSION; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; LUNG VENTILATION; LUNG WEIGHT; NONHUMAN; PEAK INSPIRATORY PRESSURE; PRIORITY JOURNAL; RABBIT;

ANIMALS; CALCIMYCIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOPROSTENOL; FEMALE; FLUOROCARBONS; IONOPHORES; LEUKOTRIENE B4; LUNG; LUNG INJURY; ORGAN SIZE; POSITIVE-PRESSURE RESPIRATION; PULMONARY ARTERY; PULMONARY CIRCULATION; PULMONARY EDEMA; RABBITS; THROMBOXANE A2; VASCULAR RESISTANCE; VOLATILIZATION;

EID: 77955430972     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.03.009     Document Type: Article

References (30)

1. Greenspan J.S., Wolfson M.R., Rubenstein S.D., Shaffer T.H. Liquid ventilation of human preterm neonates. J Pediatr 1990, 117:106-111.
2. Hirschl R.B., Pranikoff T., Gauger P., Schreiner R.J., Dechert R., Bartlett R.H. Liquid ventilation in adults, children, and full-term neonates. Lancet 1995, 346:1201-1202.
3. Hirschl R.B., Pranikoff T., Wise C., Overbeck M.C., Gauger P., Schreiner R.J., et al. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA 1996, 275:383-389.
4. Leach C.L., Greenspan J.S., Rubenstein S.D., Shaffer T.H., Wolfson M.R., Jackson J.C., et al. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. The LiquiVent Study Group. N Engl J Med 1996, 335:761-767.
5. Kacmarek R.M., Wiedemann H.P., Lavin P.T., Wedel M.K., Tutuncu A.S., Slutsky A.S. Partial liquid ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2005, 173:882-889.
6. Wolfson M.R., Hirschl R.B., Jackson J.C., Gauvin F., Foley D.S., Lamm W.J., et al. Multicenter comparative study of conventional mechanical gas ventilation to tidal liquid ventilation in oleic acid injured sheep. ASAIO J 2008, 54:256-269.
7. Bleyl J.U., Ragaller M., Tscho U., Regner M., Kanzow M., Hubler M., et al. Vaporized perfluorocarbon improves oxygenation and pulmonary function in an ovine model of acute respiratory distress syndrome. Anesthesiology 1999, 91:461-469.
8. Kandler M.A., von der Hardt K., Schoof E., Dotsch J., Rascher W. Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. Am J Respir Crit Care Med 2001, 164:31-35.
9. Ragaller M., Bleyl J., Tscho U., Winkler T., Regner M., Rasche S., et al. Effects of inhalation of perfluorocarbon aerosol on oxygenation and pulmonary function compared to PGI2 inhalation in a sheep model of oleic acid-induced lung injury. Intensive Care Med 2001, 27:889-897.
10. Rossaint R., Falke K.J., Lopez F., Slama K., Pison U., Zapol W.M. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993, 328:399-405.
11. Walmrath D., Schneider T., Pilch J., Grimminger F., Seeger W. Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 1993, 342:961-962.
12. Dellinger R.P. Inhaled nitric oxide in acute lung injury and acute respiratory distress syndrome. Inability to translate physiologic benefit to clinical outcome benefit in adult clinical trials. Intensive Care Med 1999, 25:881-883.
13. Bleyl J.U., Ragaller M., Tscho U., Regner M., Hubler M., Kanzow M., et al. Changes in pulmonary function and oxygenation during application of perfluorocarbon vapor in healthy and oleic acid-injured animals. Crit Care Med 2002, 30:1340-1347.
14. von der Hardt K., Kandler M.A., Fink L., Schoof E., Dotsch J., Bohle R.M., et al. Laser-assisted microdissection and real-time PCR detect anti-inflammatory effect of perfluorocarbon. Am J Physiol Lung Cell Mol Physiol 2003, 285:L55-L62.
15. Gama de Abreu M., Quelhas A.D., Spieth P., Brauer G., Knels L., Kasper M., et al. Comparative effects of vaporized perfluorohexane and partial liquid ventilation in oleic acid-induced lung injury. Anesthesiology 2006, 104:278-289.
16. Spieth P.M., Knels L., Kasper M., Domingues Q.A., Wiedemann B., Lupp A., et al. Effects of vaporized perfluorohexane and partial liquid ventilation on regional distribution of alveolar damage in experimental lung injury. Intensive Care Med 2007, 33:308-314.
17. Koch T., Ragaller M., Haufe D., Hofer A., Grosser M., Albrecht D.M., et al. Perfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages. Anesthesiology 2001, 94:101-109.
18. Smith T.M., Steinhorn D.M., Thusu K., Fuhrman B.P., Dandona P. A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med 1995, 23:1533-1539.
19. Varani J., Hirschl R.B., Dame M., Johnson K. Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy. Shock 1996, 6:339-344.
20. Seeger W., Walmrath D., Grimminger F., Rosseau S., Schutte H., Kramer H.J., et al. Adult respiratory distress syndrome: model systems using isolated perfused rabbit lungs. Methods Enzymol 1994, 233:549-584.
21. Seeger W., Menger M., Walmrath D., Becker G., Grimminger F., Neuhof H. Arachidonic acid lipoxygenase pathways and increased vascular permeability in isolated rabbit lungs. Am Rev Respir Dis 1987, 136:964-972.
22. Seeger W., Ernst C., Walmrath D., Neuhof H., Roka L. Influence of the thromboxane antagonist BM 13.177 on the arachidonic acid-induced increase in pulmonary vascular resistance and permeability in rabbit lungs. Thromb Res 1985, 40:793-805.
23. Tilley S.L., Coffman T.M., Koller B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001, 108:15-23.
24. Gama d.A., Wilmink B., Hubler M., Koch T. Vaporized perfluorohexane attenuates ventilator-induced lung injury in isolated, perfused rabbit lungs. Anesthesiology 2005, 102:597-605.
25. Shashikant M.P., Badellino M.M., Cooper B., Shaffer T.H., Myers S.I., Wolfson M.R. Physicochemical properties of perfluorochemical liquids influence ventilatory requirements, pulmonary mechanics, and microvascular permeability during partial liquid ventilation following intestinal ischemia/reperfusion injury. Crit Care Med 2002, 30:2300-2305.
26. Woods C.M., Neslund G., Kornbrust E., Flaim S.F. Perflubron attenuates neutrophil adhesion to activated endothelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 2000, 278:L1008-L1017.
27. Schoof E., von der Hardt K., Kandler M.A., Abendroth F., Papadopoulos T., Rascher W., et al. Aerosolized perfluorocarbon reduces adhesion molecule gene expression and neutrophil sequestration in acute respiratory distress. Eur J Pharmacol 2002, 457:195-200.
28. Obraztsov V.V., Neslund G.G., Kornbrust E.S., Flaim S.F., Woods C.M. In vitro cellular effects of perfluorochemicals correlate with their lipid solubility. Am J Physiol Lung Cell Mol Physiol 2000, 278:L1018-L1024.
29. Wolfson M.R., Greenspan J.S., Shaffer T.H. Liquid-assisted ventilation: an alternative respiratory modality. Pediatr Pulmonol 1998, 26:42-63.
30. Westcott J.Y., McDonnell T.J., Bostwick P., Voelkel N.F. Eicosanoid production in isolated perfused lungs stimulated by calcium ionophore A23187. Am Rev Respir Dis 1988, 138:895-900.